BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25721397)

  • 1. Factors influencing survival after pancreatoduodenectomy for ductal adenocarcinoma depend on patients' age.
    Urbonas K; Gulbinas A; Smailyte G; Pranys D; Jakstaite A; Pundzius J; Barauskas G
    Dig Surg; 2015; 32(1):60-67. PubMed ID: 25721397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.
    De Reuver PR; Mittal A; Neale M; Gill AJ; Samra JS
    Surgery; 2015 Jul; 158(1):183-90. PubMed ID: 25920909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.
    Chang ST; Jeffrey RB; Patel BN; DiMaio MA; Rosenberg J; Willmann JK; Olcott EW
    Radiology; 2016 Dec; 281(3):816-825. PubMed ID: 27438167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
    van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
    Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer.
    Crippa S; Guarneri G; Belfiori G; Partelli S; Pagnanelli M; Gasparini G; Balzano G; Lena MS; Rubini C; Doglioni C; Zamboni G; Falconi M
    Eur J Surg Oncol; 2020 Aug; 46(8):1524-1531. PubMed ID: 32098733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
    Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
    Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
    Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
    Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.
    Lu L; Zhang X; Tang G; Shang Y; Liu P; Wei Y; Gong P; Ma L
    Int J Surg; 2018 May; 53():262-268. PubMed ID: 29604352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study.
    Joliat GR; Gaspar-Figueiredo S; Labgaa I; Vrochides D; Perinel J; Adham M; Demartines N; Schäfer M
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17007-17014. PubMed ID: 37740766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.
    Sauvanet A; Boher JM; Paye F; Bachellier P; Sa Cuhna A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
    J Am Coll Surg; 2015 Aug; 221(2):380-9. PubMed ID: 26206638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
    Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Time to Surgery in Patients With Resectable Pancreatic Ductal Adenocarcinoma.
    Joliat GR; Labgaa I; Gilgien J; Demartines N
    Pancreas; 2021 Jan; 50(1):104-110. PubMed ID: 33370031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of lymph node metastases detected during surgical exploration for pancreatic or periampullary cancer: a systematic review and meta-analysis.
    van Rijssen LB; Narwade P; van Huijgevoort NC; Tseng DS; van Santvoort HC; Molenaar IQ; van Laarhoven HW; van Eijck CH; Busch OR; Besselink MG;
    HPB (Oxford); 2016 Jul; 18(7):559-66. PubMed ID: 27346135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
    Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
    Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of postoperative complication after pancreatoduodenectomy for pancreatic adenocarcinoma stratified by the resectability status.
    Kondo N; Murakami Y; Uemura K; Nakagawa N; Okada K; Takahashi S; Sueda T
    J Surg Oncol; 2018 Dec; 118(7):1105-1114. PubMed ID: 29878355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
    BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
    Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.